Columbia Laboratories to Discuss Third Quarter 2012 Financial Results on November 8 Conference Call
Columbia Laboratories Inc. (Nasdaq: CBRX) will hold a conference call on November 8, 2012, to discuss financial results of the three-month period ended September 30, 2012. Frank Condella, president and chief executive officer, and Lawrence Gyenes, senior vice president, chief financial officer and treasurer of Columbia Laboratories, will host the call.
|Date:||Thursday, November 8, 2012|
|Time:||11:00 am ET|
|Dial-in numbers:||(877) 303-9483 (U.S. & Canada) or (760) 666-3584|
www.columbialabs.com in ‘Events' under the ‘Investors' tab
The teleconference replay will be available two hours after completion through Thursday, November 15, 2012, at (855) 859-2056 (U.S. & Canada) or (404) 537-3406. The conference ID for the replay is 57130054. The archived webcast will be available for one year on the Company's website, www.columbialabs.com, in the 'Investor' section under 'Events'.
About Columbia Laboratories
Columbia Laboratories, Inc. is a publicly traded specialty pharmaceutical company with a successful history of developing proprietary, vaginally administered products for women's health indications. For more information, please visit www.columbialabs.com.
Columbia Laboratories, Inc.
Lawrence A. Gyenes, 973-486-8860
Senior Vice President, CFO & Treasurer
The Trout Group LLC
Seth Lewis, 646-378-2952